Durable Complete Remission With Combination of Stereotactic Body Radiation Therapy (SBRT) and Talimogene Laherparepvec (TVEC) Followed by Ipilimumab in Refractory Metastatic Melanoma

Publication/Presentation Date

9-2022

Volume

14

Issue

9

Disciplines

Medicine and Health Sciences

PubMedID

36312666

Department(s)

Department of Medicine, Hematology-Medical Oncology Division, Department of Pathology and Laboratory Medicine, Department of Radiation Oncology, Lehigh Valley Topper Cancer Institute

Document Type

Article

Share

COinS